EHP-102 is an oral pharmaceutical product candidate derived from cannabigerol (CBG), another key cannabinoid molecule. The novel active molecule of EHP-102 has been modified to provide even more potent effects compared to CBG by also affecting PPARγ, a key molecular target for the treatment of Huntington’s and Parkinson’s diseases, as well as other pathways involved in the pathophysiology of neurodegenerative diseases.
MedKoo Cat#: 463861
Name: EHP-102
CAS#: 1807652-43-2
Chemical Formula: C23H35NO3
Exact Mass: 373.2617
Molecular Weight: 373.54
Elemental Analysis: C, 73.96; H, 9.44; N, 3.75; O, 12.85
The following data is based on the product molecular weight 373.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
